IN VITRO TEST SYSTEMS FOR EVALUATING CHEMOTHERAPIES AGAINST HIV NIH GUIDE, Volume 23, Number 33, September 16, 1994 RFP AVAILABLE: NIH-NIAID-DAIDS-95-19 P.T. Keywords: National Institute of Allergy and Infectious Diseases The Developmental Therapeutics Branch, Basic Research and Development Program, Division of AIDS of the National Institute of Allergy and Infectious Diseases (NIAID), NIH has a requirement for in vitro test systems to evaluate chemotherapies against HIV. The Contractor will be required to do the following with compounds provided by the Government: evaluate potential therapeutic agents in cell-based in vitro assays for anti-HIV efficacy and cytotoxicity; analyze the data generated in antiviral and cytotoxicity assays; and provide an assessment of the experimental data. The RFP contains mandatory qualification criteria that excludes pharmaceutical companies from participating as an offeror or subcontractor. A pharmaceutical company is defined as an organization which sells drugs or other therapeutic agents for profit. This announcement is a recompetition for two current contracts (Emory University N01-AI-05078 and IIT Research Institute N01-AI-05077). It is anticipated that there will be two awards. The issuance of the RFP will be on or about September 16, 1994 and proposals will be due by COB on or about December 9, 1994. It is anticipated that two level-of- effort type cost-reimbursement contracts will be awarded and that the period of performance for this contract will be five years. The approximate start date of the contract will be on or about July 9, 1995. INQUIRIES A short-form version of the RFP will be available, for informational purposes, which includes only the background information, the full Statement of Work, and Evaluation Criteria. There is sufficient information in this document to enable prospective offerors to determine if they have the expertise/capability to meet the Government's requirements. A full-text version will also be available, which includes all the necessary information, business forms, etc., in order to submit a proposal. Request the short-form RFP first, then the full-text version of the RFP. FAX requests are acceptable, but written requests containing two self-addressed mailing labels are preferred. Requests for the RFP are to be directed to: Mr. Ross Kelley Contract Management Branch National Institute of Allergy and Infectious Diseases Solar Building, Room 3C07 6003 Executive Boulevard, MSC 7610 Bethesda, MD 20892-7610 Telephone: (301) 402-2234 FAX: (301) 402-0972) This advertisement does not commit the Government to award a contract. No collect calls will be accepted. .
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files. |